Indeed, ablation of BLT1 in syngeneic mice subcutaneously transplanted with cervical, melanoma, or breast cancer cell lines resulted in increased tumor growth, which was abolished after depletion of CD8+ T cells. The gene discussed is CD8A; the disease is breast carcinoma.